All Infectious Disease articles – Page 13
-
NewsAs US measles cases rise, views of MMR vaccine safety and effectiveness – and willingness to recommend it – drop
As U.S. measles cases rise, a new nationally representative panel survey finds a small but significant drop in the proportion of the public that would recommend that someone in their household get the MMR vaccine, which protects against measles, mumps, and rubella.
-
NewsClostridioides difficile: A suspected pro-carcinogenic bacterium for gastrointestinal tumors
A new review proposes that C. difficile infection (CDI) may be a previously underappreciated pro-carcinogenic factor in CRC and possibly other gastrointestinal cancers, offering a fresh angle for research and prevention strategies.
-
NewsGlobal study to evaluate whether dengue outbreaks can be anticipated earlier
Thousands of dengue forecasting models have been published, but few have been tested in real public-health settings. E-Dengue is a new open-source, user-friendly software system tailored for district-level decision-making.
-
News4 million euros for study with personalized phage therapy
UMC Utrecht has received a grant of 4 million euros for the first clinical study in the Netherlands involving a customized therapy with bacteriophages for patients with recurrent urinary tract infections.
-
CareersScientific Event Travel Grant: how the Safepork conference surpassed my expectations
Shan Goh from the University of Hertfordshire reports back on the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork held in Rennes, France, in October. Shan was supported with a Scientific Event Travel Grant awarded by AMI.
-
NewsA new study reveals the microbial biodiversity of dehesa soil
A study reveals the underground interactions between fungi and oomycetes in twenty Andalusian dehesas, wooded pasturelands typical of the Iberian Peninsula, making it possible to identify the role of water as the main driver of microorganism diversity and to shed new light on the pathogen responsible for la seca.
-
NewsCOVID-19 leaves a lasting mark on the human brain
COVID-19 does not just affect the respiratory system, but also significantly alters the brain in people who have fully recovered from the infectious disease, highlighting the long-term neurological impact of the virus.
-
NewsNew one-two punch could knock out drug-resistant TB
Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.
-
NewsA new way to diagnose deadly lung infections and save lives
Researchers have found a way to identify lung infections in critically ill patients by pairing a generative AI analysis of medical records with a biomarker of lower respiratory infections.
-
NewsNew method accelerates resistance testing in urinary tract infections
Researchers have developed two methods that allow urine samples to be tested directly for antibiotic susceptibility. Because the procedures do not require standardized bacterial suspensions, the time to result is reduced by up to 24 hours compared to conventional testing.
-
CareersCBCTA 2024 oral presentation winners: Isabella and Lia take home the honours
Letters in Applied Microbiology sponsored the best oral presentation award at the 29th Brazilian Congress of Food Science and Technology (CBCTA 2024). Winner Isabella Bassoto Xavier and runner-up Lia Mariano Aquino take a dive into their research.
-
NewsWho is more likely to get long COVID?
Scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection.
-
NewsStudy uncovers new drug target for huge class of viruses
A study reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.
-
NewsOroya fever: Elucidation of disease mechanism opens possibility for novel therapy
An international research team has generated and analyzed more than 1,700 genetic variants of the pathogen that causes Oroya fever, identifying two proteins that Bartonella requires for the destruction of red blood cells.
-
NewsNew method means contaminated bathing water easier to detect
A new method can provide both faster and more complete answers on whether the water is safe for swimming or not. The innovation has been successfully tested in Helsingborg, where the response time has been reduced from several days to just a few hours.
-
NewsStrategic advancement of second-generation fungal vaccine VXV-01 through Phase 1 trials
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) have announced that the second-generation fungal vaccine candidate known as VXV‑01 is poised to move forward in development up to and including Phase 1 clinical evaluation.
-
NewsA testing paradox for sexually transmitted infections
Surveillance evidence shows an increase in people infected with other STIs after initiating PrEP. A new study provides a counterintuitive explanation revealing a testing paradox: even when the observed cases increase, the true numbers of STIs can decrease.
-
NewsModulating key interaction prevents virus from entering cells
Researchers have found a way to modulate a common virus protein to prevent viruses from entering cells where it can cause illness. They were able to find and block an important interaction at the molecular level that allows the herpes virus to enter cells.
-
NewsImmune system keeps mucosal fungi in check
Researchers investigating the mechanisms that keep the fungus under control on our mucosa shed light on how homeostasis is maintained through the fine-tuned interplay between Candida albicans and the epithelial barrier on the one hand, and the immune system on the other hand.
-
NewsStreptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood-brain barrier permeability
Streptococcus suis serotype 2 (SS2) is an emerging zoonotic pathogen that causes meningitis in humans and pigs. Researchers have investigated the role and mechanism of the SS2 Clp in promoting the passage of the bacterium across the blood-brain barrier (BBB).